These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7433481)

  • 1. Different dopaminergic mechanisms for amfonelic acid, amphetamine and apomorphine.
    Schechter MD
    Pharmacol Biochem Behav; 1980 Oct; 13(4):497-500. PubMed ID: 7433481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amfonelic acid: similarity to other dopamine agonists.
    Schechter MD
    Pharmacol Biochem Behav; 1987 Feb; 26(2):413-6. PubMed ID: 3575360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similarity between (+)-amphetamine and amfonelic acid.
    Aceto MD; Rosecrans JA; Young R; Glennon RA
    Pharmacol Biochem Behav; 1984 Apr; 20(4):635-7. PubMed ID: 6728880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of behavioral effects of cathinone, amphetamine and apomorphine.
    Schechter MD; Rosecrans JA; Glennon RA
    Pharmacol Biochem Behav; 1984 Feb; 20(2):181-4. PubMed ID: 6718445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus effects of a low dose of apomorphine in the rat.
    Tang AH; Franklin SR
    Psychopharmacology (Berl); 1987; 91(1):61-6. PubMed ID: 3103160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haloperidol-induced supersensitivity to the discrimination of apomorphine.
    Schechter MD
    Eur J Pharmacol; 1981 Sep; 74(4):343-6. PubMed ID: 7297600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphetamine discrimination as a test for anti-parkinsonism drugs.
    Schechter MD
    Eur J Pharmacol; 1977 Jul; 44(1):51-6. PubMed ID: 885158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral effects of amfonelic acid in rats: a comparison with amphetamine and apomorphine.
    Jeste DV; Perlow MJ; Wyatt RJ; Stoff DM
    Commun Psychopharmacol; 1979; 3(1):41-7. PubMed ID: 38031
    [No Abstract]   [Full Text] [Related]  

  • 9. Lack of effect of choline and narcotic antagonists upon apomorphine discrimination.
    Schechter MD
    Eur J Pharmacol; 1980 Nov; 68(2):187-91. PubMed ID: 7202485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of selective dopamine receptor agonists in rats trained to discriminate apomorphine from saline.
    Woolverton WL; Kamien JB; Goldberg LI
    Pharmacol Biochem Behav; 1985 Apr; 22(4):577-81. PubMed ID: 3873077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dopamine agonists and fenfluramine on discriminative behavior in obese and lean Zucker rats.
    Schechter MD; Finkelstein JA
    Pharmacol Biochem Behav; 1985 Jul; 23(1):7-11. PubMed ID: 4034621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of opiates on the discriminative stimulus properties of dopamine agonists.
    Hernandez LL; Holohean AM; Appel JB
    Pharmacol Biochem Behav; 1978 Oct; 9(4):459-63. PubMed ID: 733832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that the stimulus properties of apomorphine are mediated by both D1 and D2 receptor activation.
    Schechter MD; Greer NL
    Life Sci; 1987 Jun; 40(25):2461-71. PubMed ID: 2953944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discriminative stimulus properties of the D-1 agonist SK&F 38393 and the D-2 agonist (-)-NPA are mediated by separate mechanisms.
    Arnt J
    Life Sci; 1988; 42(5):565-74. PubMed ID: 2963185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apomorphine increases ethanol discrimination.
    Schechter MD
    Pharmacol Biochem Behav; 1985 Feb; 22(2):179-82. PubMed ID: 3983211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic activity of quipazine.
    Schechter MD; Concannon JT
    Pharmacol Biochem Behav; 1982 Sep; 17(3):393-7. PubMed ID: 7146043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocaine cue in rats as it relates to subjective drug effects: a preliminary report.
    Colpaert FC; Niemegeers CJ; Janssen PA
    Eur J Pharmacol; 1976 Nov; 40(1):195-9. PubMed ID: 991926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a direct dopaminergic effect of lisuride.
    Schechter MD
    Pharmacol Biochem Behav; 1984 Aug; 21(2):185-9. PubMed ID: 6483929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CGS 10746B is able to attenuate the effects of amphetamine: further evidence for dopaminergic mediation.
    Schechter MD; Boja JW
    Pharmacol Biochem Behav; 1988 Aug; 30(4):1089-92. PubMed ID: 2906435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine potentiation of apomorphine discrimination.
    Schechter MD
    Pharmacol Biochem Behav; 1980 Aug; 13(2):307-9. PubMed ID: 6251484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.